Walleye Capital’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $161K | Sell |
4,416
-32,671
| -88% | -$1.19M | ﹤0.01% | 1447 |
|
|
2025
Q1 | $1.34M | Buy |
37,087
+25,890
| +231% | +$937K | 0.01% | 747 |
|
|
2024
Q4 | $471K | Sell |
11,197
-37,920
| -77% | -$1.6M | ﹤0.01% | 1189 |
|
|
2024
Q3 | $2.73M | Sell |
49,117
-341,475
| -87% | -$19M | 0.01% | 633 |
|
|
2024
Q2 | $16.1M | Buy |
390,592
+123,951
| +46% | +$5.09M | 0.03% | 149 |
|
|
2024
Q1 | $12.4M | Buy |
266,641
+114,914
| +76% | +$5.37M | 0.02% | 208 |
|
|
2023
Q4 | $7.26M | Sell |
151,727
-78,278
| -34% | -$3.74M | 0.02% | 262 |
|
|
2023
Q3 | $8.2M | Buy |
230,005
+210,141
| +1,058% | +$7.49M | 0.02% | 265 |
|
|
2023
Q2 | $916K | Sell |
19,864
-1,310
| -6% | -$60.4K | ﹤0.01% | 775 |
|
|
2023
Q1 | $849K | Buy |
21,174
+15,906
| +302% | +$638K | 0.01% | 803 |
|
|
2022
Q4 | $244K | Buy |
+5,268
| New | +$244K | ﹤0.01% | 1275 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 2658 |
|